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In several liver diseases thebiliary transport is disturbed, resulting in, for exam-
ple, jaundice and cholestasis. Many of these symptoms can be attributed to
altered regulation ofhepatic transporters. Organic anion transport, mediated by
the canalicular multispecific organic anion transporter (cmoat), has been exten-
sively studied. The regulation ofintracellular vesicular sorting ofcmoat by pro-
tein kinase C and protein kinaseA, and the regulation ofcmoat-mediated trans-
port in endotoxemic liver disease, have been examined. The discovery that the
multidrug resistance protein (MRP), responsible formultidrug resistance in can-
cers, transports similar substrates as cmoat led to the cloning of a MRP homo-
logue from rat liver, named mrp2. Mrp2 turned out to be identical to cmoat. At
present there is evidence that at least two mrp's are present in hepatocytes, the
original mrp (mrp1) on the lateral membrane, and mrp2 (cmoat) on the canalic-
ular membrane. The expression of mrpl and mrp2 in hepatocytes appears to be
cell-cycle-dependent and regulated in a reciprocal fashion. These findings show
that biliary transport of organic anions and possibly other canalicular transport
is influenced by the entry ofhepatocytes into the cell cycle. The cloning of the
gene for cmoat opens up new possibilities to study the regulation of hepatic
organic anion transport.
HEPATIC TRANSPORT OF ORGANIC ANIONS
Mutant rat strains, named TR- [1], GY [2] and EHBR [3, 4], with a conjugated hyper-
bilirubinemia, led to the discovery of the canalicular multispecific organic anion trans-
porter(cmoat)b. ThisATP-dependent transporter [5] mediates the biliary excretion ofnon-
bile acid organic anions. Substrates for cmoat include bilirubin diglucuronide [6], oxi-
dized glutathione (GSSG) [5, 7], leukotreine C4 (LTC4) [8], and a range of other glu-
tathione S-conjugates [9, 10]. Also sulfated and glucuronidated bile salts are transported
by cmoat [11, 12]. The latter studies suggest that cmoat transports organic anions with at
least two separate negative charges. Recently it was demonstrated that the multidrug resis-
tance protein (MRP), responsible for non-P-glycoprotein-dependent multidrug resistance,
transports similar substrates as cmoat in an ATP-dependent fashion [13-16]. Substrates
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include leukotriene C4 (LTC4), glutathione-dinitrophenyl (GS-DNP) and oxidized glu-
tathione (GSSG). The MRP gene has been cloned from a doxorubicin-resistant small cell
lung cancer cell line that exhibits non-P glycoprotein-mediated multidrug resistance [17].
MRP is an 1531-amino acid, 190 kD, N-glycosylated integral membrane protein, encod-
ed by a 6.5 kilobase mRNA (for reviews see Refs. [18-21]). The similarity in substrate
specificity suggested that MRP may be identical to CMOAT. However, expression ofMRP
in normal liver is very low [22, 23] and MRP is localized to the lateral membrane in hepa-
tocytes [24]. These similarities between MRP and CMOAT led to the cloning of a homo-
logue ofmrp, called cmrp or mrp2, from rat liver [25, 26]. The mrp2 protein is located on
the canalicular membrane and is absent in the TR- and the EHBR rat liver. Rat mrp2 con-
sists of 1541 amino acids with a molecular mass of 190-200 kD [25, 26]. The mutation in
the TR- rat is due to a one-base pair deletion resulting in a frame shift and the introduc-
tion of a stop codon. The untranslated mutated mrp2 mRNA appears rapidly degraded
[25]. The human MRP2 has also been cloned [27] and has been shown to be defective in
livers from Dubin-Johnson patients [28]. These data suggest that mrp2 is identical to
cmoat. Therefore, at least two mrp's are present in the rat hepatocyte: one lateral form
(mrpl) and one apical form (mrp2, cmrp or cmoat). To avoid confusion the "mrpl" and
"mrp2" nomenclature will be used in the rest of this paper.
Several studies suggest that, besides mrpl and mrp2, other, mrp-like, organic anion
transporters with different substrate specificities probably exist in the hepatocyte. For
example, impairment ofbiliary organic anion transport in the TR- rat differs for different
substrates: transport of bilirubin-diglucuronide is more affected than the transport of
bilirubin-ditaurate, which is almost normal in the TR-rat [29]. Studies with isolated mem-
brane vesicles also indicate that organic anion transporters other than mrp2/cmoat proba-
bly are present on the canalicular membrane [30, 31]. These transporters may provide
additional or alternative biliary secretion routes.
ASSAYS TO MEASURE AND DETECT ORGANIC
ANION TRANSPORT ACTIVITY
Before cmoat was cloned, most data were derived from changes in transport activity,
since no antibody was available. Using radioactive labeled glutathione-dinitrophenyl (GS-
DNP) as a cmoat substrate, organic anion efflux can be measured in freshly isolated [7]
and cultured hepatocytes [32]. GS-DNP is formed intracellularly from [14C]1-chloro-2,4-
dinitrobenzene (CDNB). Excretion from isolated hepatocytes is mainly mediated via
mrp2, since GS-DNP excretion from isolated mutant TR- rat hepatocytes is considerably
lower. A more convenient assay, avoiding the use ofradioactivity, determines the efflux of
the fluorescent glutathione S-conjugate, glutathione-methylfluorescein (GS-MF) [22].
Cells are incubated with the non-fluorescent chloromethylfluorescein diacetate (CMFDA)
at 10°C. The CMFDA is taken up by the cells via diffusion, and the acetate groups are
removed intracellularly by esterases and the chloromethyl group is conjugated with GSH
by glutathione S-transferases. When the 10°C medium is changed to a medium at 37°C,
the initial efflux ofthe fluorescent product GS-MF can be determined. Quantitation ofthe
fluorescence can be done in a microtiter plate using a fluorescence ELISA plate reader.
Under certain conditions, mrp activity may be visualized intracellularly using fluo-
rescent mrp substrates such as carboxyfluorescein [33], glutathione-methylfluorescein
(GS-MF) [22] the calcium indicator fluo-3 [34], calcein [35] and glutathione-bimane
(GS-B) [36]. GS-B, formed from the non-fluorescent monochlorobimane (MCB), was
shown to be transported into intracellular structures in 24 hr cultured rat hepatocytes
[36]. Also, in HepG2 hepatoma cells and hepatocytes immortalized with SV-40 large T
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Figure 1. Accumulation of glu-
tatuione-methylfluorescein (GS-
MF) in intracellular vesicular
compartments in HepG2 cells.
HepG2 cells, grown on coverslips, N. _ were loaded with 2.5 gM
chloromethylfluorescein diacetate
(CMFDA) for 15 min at 37°C.
Cover slips were transferred to
fresh medium and stored on ice.
WRX- Intracellular accumulation of the
MRP-substrate GS-MF was visual-
ized by confocal microscopy. GS-
'NJ sMF accumulates in small intracel- I 1N i - _ lular vesicles (small arrows) and
large (apical) vacuoles (large
arrow), indicating MRP transport
N _ activity is present. N: nucleus.
antigen, fluorescent organic anion-accumulating vesicles are present, as visualized using
GS-MF [22] (see also Figure 1). These vesicles may either originate from endocytosed
plasma membrane or from the Golgi compartment. Both MRP1 and MRP2 can mediate
this vesicular transport.
CYCLIC AMP STIMULATED SORTING OF ENDOCYTOSED
MRP2-CONTAINING VESICLES
The above-mentioned GS-B accumulating vesicles found in normal cultured rathepa-
tocytes are not observed in mutant TR- cells [36]. This indicates that mrp2 is also active
in intracellular vesicles. In freshly isolated hepatocytes, these organic anion-accumulating
vesicles are not detected. However, they gradually appeared upon prolonged culture, con-
comitantly with adecrease in GS-DNP efflux from the cells.After24 hrofculture, 70 per-
cent ofmrp2 activity has disappeared from theplasma membrane [32]. These results indi-
cate that after disruption ofcell polarity by collagenase isolation ofthe hepatocytes, rem-
nants ofapical membrane containing mrp2 activity are endocytosed and accumulate intra-
cellularly. Disruption of cell polarity also takes place during biliary obstruction.
Hepatocytes isolated from bile duct ligated rats show a similar reduction of GS-DNP
transport of 67 percent within 48 hr after obstruction [37]. Therefore, the disappearance
oftransport activity in this in vivo model may result at least partly from apical endocyto-
sis ofmrp2.
The fate ofthese endocytosed mrp2-containing apical membranes is different in iso-
lated hepatocyte couplets, which have retained their polarity [38]. This was studied with
GS-MF in order to visualize intracellular compartments containing mrp2 activity. Using
confocal microscopy, it could be shown that in 3 hr cultured hepatocyte couplets, GS-MF
accumulates in the canalicular lumen, in an intracellular (vesicular) network and in peri-
canalicular vesicles, identified as lysosomes. Incubation ofthe cells with dibutyrylcAMP
(DBcAMP) for the last 2 hr of culture strongly stimulates GS-MF secretion into the
canalicular lumen and significantly increased canalicular membrane circumference.
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Under these conditions, the GS-MF containing intracellular structures have almost disap-
peared. A similar effect of DBcAMP has been observed on the apical targeting of the
canalicular C1-/HC03- exchanger [39] and on canalicular bile acid transport activity [40].
These data suggest that cAMP stimulates the fusion of vesicles containing canalicular
transporters with the remaining canalicular membrane ofthe couplet. This phenomenon is
inhibited by nocodazole [38, 40] and by bafilomycin Al [41]. Nocodazole is an inhibitor
of microtubule polymerization, and bafilomycin inhibits vesicular acidification. These
results indicate a dependency of cAMP-stimulated sorting of mrp2 on microtubules and
acidic compartments. A similar effect of cAMP on apical exocytosis from a subapical
compartment has been observed in MDCK cells [42-44]. In contrast to the hepatocyte
couplet model, DBcAMP did not effect efflux from non-polarized hepatocytes [45]. Thus,
an intact apical domain may be essential for this effect. Stimulation of apical exocytosis
by DBcAMP is not confined to the couplet system. Hayakawa et al. [46] showed that
DBcAMP stimulates exocytosis of horseradish peroxidase into bile of the isolated per-
fused rat liver. Gatmaitan et al. [47], measured a 2-fold increase in both GS-DNP and tau-
rocholate transport, in canalicular membrane vesicles isolated from rats injected with
DBcAMP. The effect of DBcAMP was inhibited by colchicine. These data also suggest
that in vivo cAMP stimulates a microtubule-dependent movement of mrp2 and cBAT to
the canalicular membrane. Therefore, stimulation of PKA may activate a regulatory sys-
tem that determines the secretory capacity ofthe canalicular membrane.
REGULATION OF MRP1 AND MRP2 BY PROTEIN KINASE C
Mrp2-mediated transport can be manipulated by activators and inhibitors of protein
kinase C (PKC) [45]. Short-time incubations (3 min) offreshly isolated hepatocytes with
the phorbol ester PMA and the hormone vasopressin, both activators of PKC, stimulated
GS-DNP efflux from the cells by more than 50 percent. An inhibitor of PKC, stau-
rosporine, inhibited efflux by 53 percent. In contrast, incubation of the cells with
glucagon, forskolin and dibutyryl-cAMP (DBcAMP), all stimulators of PKA, did not
influence organic anion transport. These results suggest that PKC is somehow involved in
the regulation ofmrp2-mediated organic anion transport. However, the nature ofthis reg-
ulation is not clear. Two possible mechanisms may be considered. First, a direct phos-
phorylation ofthe carrierby PKC may result in an increased transport activity as was sug-
gested for P-glycoprotein [48]. However, phosphorylation studies of mrp2 have not yet
been performed. Secondly, activation of PKC may regulate the number of carriers on the
plasma membrane by mobilization of an intracellular pool oftransporters to fuse with the
plasma membrane as was shown for the insulin-responsive glucose transporter and the
cystic fibrosis transmembrane conductance regulator (CFTR) (for reviews see Refs. [49,
50]). Evidence for the latter mechanism comes from observations made by Bruck et al.
[51] who showed that both vasopressin and phorbol dibutyrate were able to stimulate api-
cal exocytosis of the fluid phase marker horseradish peroxidase into bile of the isolated
perfused liver. This process was inhibitable by the PKC inhibitor H7, suggesting that PKC
is involved in apical exocytosis.
PKC also appears to regulate MRP1 transport activity. Ma et al. [52] found that drug
accumulation in the MRP1 overexpressing leukemia cell line HL60/ADR is increased by
treating the cells with H-7, staurosporine or chelerythrine, all more or less specific PKC
inhibitors. MRP1 is phosphorylated, mainly on serine residues, in these cells. Treatment
ofcells with the above-mentioned PKC inhibitors reduces or even abolishes MRP1 phos-
phorylation, suggesting a correlation between PKC-mediated phosphorylation and the
observed inhibition of transport activity. In another study with HL60/ADR and
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GLC4/ADR cells, areduction ofMRP1 activity has been reported upon treatment with the
specific PKC inhibitor bisindolylmaleimide [53]. No such studies have been performed
with hepatic MRP1. These results suggest that both MRP1 and MRP2 may be regulated
by a PKC-dependent mechanism. The importance ofthis regulatory mechanism to biliary
organic anion secretion and bile formation has to be determined.
REGULATION OF MRP2 DURING ENDOTOXEMIA
Impairment ofhepatic bilirubin transport, leading to hyperbilirubinemia, is frequent-
ly observed during sepsis [54-57]. Several factors may be involved in the inhibition of
hepatobiliary organic anion transport. Acute effects ofendotoxin were studied in the iso-
lated perfused rat liver. Endotoxin present in the perfusate of a recirculating perfused rat
liver causes an acute reduction (36 percent) ofthe biliary BSP excretion, accompanied by
a decrease in both bile salt-independent bile flow and perfusate flow [58, 59]. Other mod-
els have been developed to study more long-term effects of LPS on biliary transport.
Studies in perfused endotoxemic livers, isolated from rats 18 hr after injection with a sin-
gle, relatively low dose ofLPS, show diminished bilirubin (-49 percent) and taurocholate
(- 28 percent) transport [60]. Bile salt-independent bile flow is reduced by 42 percent in
this study. This has been confirmed in recent transport studies with basolateral and
canalicular membrane vesicles, isolated from endotoxemic rat livers [61, 62]. Also, the
canalicular excretion ofanothermrp2 substrate, LTC4, is reduced by 50 percent in the per-
fused endotoxemic rat liver [63]. Others report an 86 percent inhibition of bile acid trans-
port, using a higher dose ofendotoxin in in situ perfused livers [64]. These data indicate
that with a low doses ofendotoxin, bile acid transport is less affected than organic anion
transport.
The reduction of bilirubin transport in endotoxemic livers can be partially attributed
to impaired uptake [60]. However, the inhibition oforganic anion transport is largely due
to a reduction in canalicular cmoat/mrp2 transport activity as was demonstrated in hepa-
tocytes isolated from endotoxemic livers [65]. The down-regulation of mrp2 and cBAT
activity during endotoxemia is a gradual process with a maximal inhibition 12 hr after
endotoxin injection [62, 65]. This is followed by a slow recovery in 4 to 5 days. Evidence
from kinetic studies suggests that the reduction in mrp2 and cBAT-mediated transport is
due to areduced number oftransporters [62]. Trauner et al. recently reported a 96 percent
decrease in mrp2 mRNA and a 75 percent decrease in mrp2 protein levels, 16 hr after LPS
injection [66]. Also bile acid uptake via the Na+-dependent bile acid transporter (Ntcp) is
substantially decreased due to decreased transcription and translation [61, 67].
How down-regulation of hepatic transport during endotoxemia is brought about is
still an open question. Altered regulation of mrp2 by PKC appears not to be responsible,
since stimulation ofcanalicular organic anion transport could not restore normal transport
activity in endotoxemic hepatocytes [65]. Interestingly, Wettstein et al. found a 20 percent
stimulation ofbiliary LTC4 transport in endotoxemic livers by hypotonic media- or glut-
amine-induced cell swelling [63]. No significant effect was observed in normal liver. This
suggest that in endotoxemic hepatocytes an intracellular population of mrp2-containing
vesicles exist, able to fuse with the canalicular membrane, which is not present in normal
hepatocytes. The nature ofthis intracellular population is unclear but probably represents
mrp2 on their way to lysosomes to be degraded. Thus, inhibition of canalicular transport
appears to result from inhibition ofmRNA synthesis, which causes a reduced synthesis of
transporters. This, in turn, leads to a reduced number of transporters on the canalicular
membrane, because endocytosed mrp2 is not replenished with newly synthesized trans-
porters.
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Increasing evidence suggests that endotoxin-induced cytokines such as tumor necro-
sis factor a (TNFx) and interleukin-1 (IL-1) play an important role in mediating the
down-regulation of hepatic transport: 1) Pretreatment of rats with dexamethasone, an
inhibitor ofcytokine production, largely prevents down-regulation oforganic anion trans-
port [65]; 2) Antibodies against TNFa prevent the down-regulation of bile acid transport
during endotoxemia [64]; 3) TNFa and IL-1, but not interleukin-6 (IL-6), induce down-
regulation of bile acid uptake and excretion [61, 67]. Cytokines may directly or indirect-
ly, influence the expression of hepatic transporters. The signal transduction pathways
involved in the down regulation of transcription of these transporters are currently
unknown. If cytokines are the main mediators of down-regulation of hepatobiliary trans-
port in sepsis, this will have implications for other situations where cytokines are pro-
duced, e.g., it may explain the impaired biliary transport in viral hepatitis.
CELL CYCLE-DEPENDENT REGULATION OF MRP1 AND MRP2
The presence oforganic anion transporters on both the lateral (mrpl) and the canalic-
ular (mrp2) membrane ofthe hepatocyte [24] seems incompatible with vectorial transport
into bile. However, compared to mrp2, mrpl expression is very low in normal hepatocytes.
With our antibodies, mrpl protein could be detected only in purified plasma membrane
fractions from isolated hepatocytes but not in crude membranes and on frozen sections
[22]. In contrast, mrpl staining was detectable in the basolateral membrane of bile duct
epithelial cells (Figure 2). No mrp2 staining was observed in these cells (unpublished
observation), which may indicate that in bile duct epithelial cells mrpl is the main glu-
tathione S-conjugate transporter. Expression of mrpl in hepatocytes is linked to prolifer-
ation. Transfection of hepatocytes with the SV40 large T antigen induces MRP1 expres-
sion. Also, in HepG2 hepatoma cells, MRP1 is highly expressed [22]. In these cells,
MRP1 can be found in lateral membranes, but not at the basal membrane. Also MRP2 is
expressed in these cells and is localized on the membranes of apical vacuoles formed
Figure 2. Localization of mrpl in
the basolateral membrane of bile
duct epithelial cells. Frozen sections
of rat liver were incubated with the
pAb mrpk5 specific for mrpl and
with a secondary FITC-labeled anti-
rabbit antibody. Staining was visual-
ized by confocal microscopy. Bile
duct epithelial cells show relatively
strong staining of mainly basolateral
membranes. Occasionally mem-
branes facing the lumen are labeled.
This may be due to poor histology.
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between the cells (Figure 3). Therefore, MRP1-mediated transport may be important in
proliferating hepatocytes but not in quiescent cells. Preliminary data in cultured hepato-
cytes confirmed this hypothesis [23]. TR-hepatocytes cultured for 4 days show a gradual
increase in organic anion (GS-MF) transport activity, which coincides with increased
mrpl protein expression. Similar experiments with normal hepatocytes show a decreased
expression of mrp2, which has almost disappeared at day 4. Correlation with cell cycle
markers c-myc and cyclin DI indicate that an increase ofmrpl expression concomitantly
with a decrease in mrp2 expression occurs in the GI phase of the cell cycle. Thus, the
expression ofmrp1 and mrp2 appears to be regulated in areciprocal fashion. Surprisingly,
the localization of mrpl depends on cell-cell contact. In hepatocytes cultured at low den-
sity, mrpl is mainly present on intracellular vesicular structures. In high density cultures,
mrpl is located in the lateral membrane, where two adjacent cells make contact (unpub-
lished observation). The function ofmrp1 in proliferating hepatocytes is not clear but may
involve transport of GSSG and lipid peroxidation products in order to maintain a proper
redox status [18, 19], which is determined by the GSSG/GSH ratio [68, 69]. These find-
ings show that biliary transport oforganic anions and possibly other canalicular transport
is negatively influenced by the entry of hepatocytes into the cell cycle. This may be due
to a transient loss ofcell polarity. Based upon these results, one can hypothesize that entry
ofhepatocytes into the cell cycle as a result ofregeneration ofa diseased liver will lead to
a diminished capacity to generate bile. This may turn out to be an important mechanism
for cholestasis in liver disease.
Figure 3. Localization ofMRP1 and MRP2 inHepG2 hepatoma cells. HepG2 cells were stained
for MRP1 (mrpk5 pAb) and MRP2 (mAb, provided by R.P.J. Oude Elferink). MRP1 staining can
be observed on membranes where two cells make contact. The mrp2 antibody stains apical vacuoles
in HepG2 (see arrows), suggesting that MRP2 is present in these vacuoles and probably is respon-
sible for the observed accumulation ofGS-MF (see Figure 1).
441442 Roelofsen et al.: Regulation ofhepatic organic anion transport
CONCLUSIONS
The cloning ofcmoat/mrp2 has provided new possibilities to study the mechanism of
the impaired canalicular excretion of organic anions observed in many liver diseases. For
example, the inhibition of organic anion transport during endotoxemia appears to be
caused by an almost complete blockade of the mrp2 mRNA synthesis. The regulatory
mechanism behind this blockade remains unclear but may involve cytokines. This brings
us to the question of how mrp2 expression is regulated on both the mRNA and protein
level, and which factors are involved in the sorting of mrp2 to the canalicular membrane.
Evidence obtained with cultured hepatocytes suggest that PKA stimulates apical sorting
of mrp2. PKC may stimulate transport activity by either phosphorylation of the carrier
and/or stimulate sorting to the canalicular membrane. Besides mrp2, a transporter with a
similar substrate specificity, called mrpl, is present in liver and located in the basolateral
membrane in hepatocytes and in bile duct epithelial cells. The expression of mrpl and
mrp2 in hepatocytes appears to be cell-cycle-dependent and regulated in a reciprocal fash-
ion: In resting, differentiated hepatocytes mrp2 is highly expressed while mrpl expression
is low, in proliferating hepatocytes this expression pattern is reversed.
These data illustrate that hepatic organic anion transport is ahighly regulated process.
The underlying mechanisms are not yet clear. Future studies on the signal transduction
pathways involved in the regulation and disregulation ofthese and other transporters in the
liver may provide us with new insights in the mechanism of cholestatic liver disease and
may lead to new therapies.
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